Ownership history in BARCLAYS PLC · 19 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in SOLENO THERAPEUTICS INC (SLNO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 157,685 | +129,285 | +455.2% | 0.00% | $7.3M | $46.30 |
| 2025 Q3 | REDUCED | 28,400 | -21,600 | -43.2% | 0.00% | $1.9M | $67.60 |
| 2025 Q3 | REDUCED | 50,000 | -120,980 | -70.8% | 0.00% | $3.4M | $67.60 |
| 2025 Q3 | ADDED | 170,980 | +32,565 | +23.5% | 0.00% | $11.6M | $67.60 |
| 2025 Q2 | ADDED | 138,415 | +60,086 | +76.7% | 0.00% | $11.6M | $83.78 |
| 2025 Q1 | ADDED | 78,329 | +68,329 | +683.3% | 0.00% | $5.6M | $71.45 |
| 2025 Q1 | REDUCED | 10,000 | -84,700 | -89.4% | 0.00% | $715K | $71.45 |
| 2025 Q1 | REDUCED | 94,700 | -31,975 | -25.2% | 0.00% | $6.8M | $71.45 |
| 2024 Q4 | ADDED | 126,675 | +74,130 | +141.1% | 0.00% | $5.7M | $44.95 |
| 2024 Q3 | ADDED | 52,545 | +31,467 | +149.3% | 0.00% | $2.7M | $50.49 |
As of 2025 Q4 — sorted by position size